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This work describes X-ray imaging of mouse using a colloid solution of silica-coated Au (Au/SiO2) nanoparticles. A
colloid solution of Au nanoparticles with a size of 16.9 nm was prepared using hydrogen tetrachloroaurate (III)
trihydrate as Au source and sodium citrate as reducing reagent. Silica coating of the Au nanoparticles was
performed by modifying the Au nanoparticle surface with (3-aminopropyl)trimethoxysilane and then by depositing
silica nuclei generated through a sol–gel reaction of tetraethyl orthosilicate in water/ethanol initiated with sodium
hydroxide on the surface-modified surface, which produced Au/SiO2 particles with a size of 136.4 nm. A computed
tomography value of the Au/SiO2 colloid solution with an Au concentration of 0.036 M was as high as 1,184.8
Hounsfield units, which was quite higher than that of a commercial X-ray contrast agent with the same iodine
concentration as the Au concentration. Tissues of mouse could be imaged by injecting the Au/SiO2 particle colloid
solution into them.
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An X-ray imaging technique is one of the quite useful
medical diagnoses [1-3] because internal organs can be
imaged without a surgical operation. Images taken with
the technique are made clearer using contrast agents
that strongly absorb X-ray [4-6]. The contrast agents,
which are commercially available, are solutions that dis-
solve iodine compounds homogeneously in solvents at
molecular level. The iodine compound molecules are
not strongly dragged in fluid because of their small sizes.
Consequently, they cannot stay in internal organs for a
long period, which provides difficulty taking steady im-
ages. In addition, the iodine-related contrast agents can-
not be used for patients in whom iodine compounds
provoke adverse events like allergic reactions [7-9].
Gold is a material that has been extensively character-
ized [10,11]. Gold also absorbs X-ray strongly, which
means that it is available for obtaining X-ray images with
high contrast. From this viewpoint, studies on the X-ray* Correspondence: ykoba@mx.ibaraki.ac.jp
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in any medium, provided the original work is pimaging ability of metallic Au nanoparticles have been
performed for development of new contrast agents that
aid the technique to image tissues in internal organs at
nanometer level [12-20]. The particles have another ad-
vantage over gold dissolved homogeneously in solvents
at molecular level. The particles are strongly dragged in
fluid because of their size which is larger than that of
molecules. Thus, their residence time in internal organs
will increase, which may allow steady imaging.
Metallic nanoparticles also have troubled us with their
toxicity in internal organs [21-28]. Formation of core-
shell particles containing Au nanoparticles as the core is
a candidate for solving the problem since the shell can
keep the particles from contacting with internal organs,
which decreases the toxicity of Au nanoparticles. Mate-
rials inert for internal organs are desirable as materials
for the shell. Silica is one of the promising materials for
the shell because it is inert for internal organs compared
to iodine compounds and metallic nanoparticles. Several
research groups have proposed methods for producing
core-shell particles composed of Au nanoparticle core
such as spheres, rods, cages, etc. and silica shell, most of
which are related to a sol–gel process [29-38]. Our re-
search group has also studied on development of ais an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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the developed method, the silica-coated particles were
fabricated in three steps. The first, second, and third
steps are (1) preparation of the Au nanoparticle colloid
solution by reducing hydrogen tetrachloroaurate(III)
with sodium citrate in water, (2) modification of the Au
nanoparticle surface with hydrophilic groups using a si-
lane coupling agent with an amino group as surface pri-
mer, and (3) formation of silica shells on the hydrophilic
surface through the sol–gel reaction of silicon alkoxide
using sodium hydroxide (NaOH) aqueous solution as a
basic catalyst in ethanol, respectively.
The colloid solution of silica-coated Au (Au/SiO2)
nanoparticles with the size of 47.3 nm prepared by the
developed method was examined for X-ray imaging of
mouse in our previous work [42]. Properties of particles
such as colloidal stability and residence time in internal
organs should be dependent on the particle size. Au/
SiO2 nanoparticles with not only the size of 47.3 nm but
also various sizes were successfully fabricated in another
work of ours [40]. The present work examines the col-
loid solution of Au/SiO2 nanoparticles with a different
size for X-ray imaging of tissues in a mouse to accumu-
late data useful for optimizing the size of contrast agent
particles.
Results and discussion
Morphology of Au/SiO2 particles
Figure 1a shows a photograph of the concentrated Au/
SiO2 particle colloid solution. A dark red solution was
obtained. No flocculation, aggregation, and precipitation
were found by passing the solution through a light and
then observing it with the naked eyes. This observation
showed the high colloidal stability of the concentrated
Au/SiO2 particle colloid solution. A transmission elec-
tron microscopy (TEM) image of the Au/SiO2 particles
in the concentrated colloid solution is shown in
Figure 1b. The average size of the particles was 136.4 ±
17.8 nm, which was close to that of the as-prepared Au/200 nm
a b
Figure 1 Concentrated Au/SiO2 particle colloid solution (a) and
TEM image of Au/SiO2 particles in the colloid solution (b).SiO2 particles in the prior work. The Au/SiO2 particles
still had a spherical core-shell structure even after the
concentrating process, which indicated that the Au/SiO2
particles produced in the present work were mechanic-
ally stable. The inductively coupled plasma (ICP) meas-
urement revealed that an actual Au concentration in the
concentrated Au/SiO2 particle colloid solution was 0.036
M, which indicated that 41.9% of Au contained in the
Au nanoparticle colloid solution was consumed for the
preparation of the concentrated Au/SiO2 particle colloid
solution.
CT values of the Au/SiO2 particle colloid solution
Figure 2b,c,d shows X-ray images of Au/SiO2 particle
colloid solutions with different actual Au concentrations.
For comparison, an X-ray image of water is also shown.
The white contrast of the image increased as the Au
concentration increased.
Figure 3 shows the computed tomography (CT) value
of the Au/SiO2 particle colloid solution versus the actual
Au concentration. The CT value increased quasi-linearly
with an increase in Au concentration and was as high as
1,184.8 Hounsfield units (HU) at an actual Au concen-
tration of 0.036 M. The straight line, which was drawn
mathematically by the least squares method of linear re-
gression, had a slope of 3.32 × 104 HU/M. According to
our previous work [42], the slope for Iopamiron®300,
which is a commercial iodine-related X-ray contrast
agent purchased from Bracco Eisai (Bunkyo-ku Tokyo,
Japan), was 4.76 × 103 HU/M. The slope for the Au/
SiO2 particle colloid solution was around seven times
larger than that for Iopamiron®300. This tendency shown
in the present work was similar to studies reported by
several researchers that resulted in CT values of Au
nanoparticles or clusters higher than commercial iodine
compound contrast agents with the same iodine concen-
tration as that of the Au [12,19,43]. The size of gold
atom is larger than that of iodine due to its larger atom
number, and the absorption coefficient for the X-ray of
gold is comparable to that of iodine. This indicates that
the projected area of Au nanoparticles in the colloid so-
lution should be larger than that of the iodine com-
pound. Consequently, such a tendency was shown for
the Au/SiO2 particle colloid solution. Accordingly, the
present result on its X-ray absorption ability expected
the Au/SiO2 particle colloid solution produced in the
present work to function as an X-ray contrast agent.
X-ray imaging of the mouse
Figure 4 shows X-ray images of the mouse prior to and
after the injection of the concentrated Au/SiO2 particle
colloid solution. Figure 5 shows CT values of various tis-
sues as a function of time after the injection. CT values
at 0 min corresponded to those prior to the injection.
a b c d
Figure 2 X-ray images of (a) water and (b, c, d) Au/SiO2 particle colloid solutions. The Au concentrations in the colloid solutions were (b) 0.011,
(c) 0.020, and (d) 0.036 M.
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such as the liver and the spleen in the images. CT values
of the liver and the spleen were 76.7 and 96.5 HU, re-
spectively, at 0 min. The contrasts of these tissues de-
creased after the injection, compared to those prior to
the injection. At 5 min after the injection, their CT
values increased markedly up to 115.0 and 120.2 HU, re-
spectively. Then, the values almost leveled out in 240
min (6 h), and they did not remarkably decrease even in
2,880 min (2 days). These tendencies were similar to the
results for the Au/SiO2 particles with the size of 47.3
nm that was reported in our previous work [40]; there
was no large difference in the dependence of the CT
value on time between the Au/SiO2 particle sizes exam-
ined. The present results indicated that the Au/SiO2 par-
ticles efficiently reached the tissues through a flow in the
blood vessels and were trapped in the tissues, and then
the tissues could be imaged. For the kidneys, their con-
trasts were almost constant for all the times examined,
in which their CT value was around 65 HU. This indi-
cated that the Au/SiO2 particles were probably recog-
nized as alien substances and were intensively trapped in
















Figure 3 CT value versus Au concentration of the AuSiO2
particle colloid solution.hydrophobic materials as foreign through interaction be-
tween proteins and the hydrophilic surface of the mate-
rials [44-48]. The surface of the Au/SiO2 particles
seemed to be hydrophilic because of silanol groups de-
rived from the silica surface of Au/SiO2 particles. The
trapping took place for the liver and the spleen with the
hydrophilic surface. Accordingly, these results proved
that the Au/SiO2 particle surface was required to be
more hydrophilic for improving their imaging function.
Conclusions
The Au/SiO2 particles with the average size of 138.9 ±
12.4 nm and the Au core size of 16.9 ± 1.2 nm that were
fabricated in our previous work were applied to X-ray
imaging in the present work. The actual Au concentra-
tion of the Au/SiO2 particle colloid solution was 0.036
M after concentrated to 1/2,000 of its original volume.
The concentrated Au/SiO2 particle colloid solution had
the CT value of 1,184.8 HU. This value was high com-
pared to that for the commercial X-ray contrast agent
with the same iodine concentration as the Au concentra-
tion, which indicated that the Au/SiO2 particle colloid
solutions were sensitive for absorption of X-ray. The in-
jection of the colloid solution into a mouse made the X-
ray images of its internal organs such as the liver and
spleen taken clearly. Accordingly, the Au/SiO2 particle
colloid solution was proved to be able to work as an X-
ray contrast agent. Further studies, in particular on the




Au nanoparticles were prepared from hydrogen
tetrachloroaurate(III) trihydrate (HAuCl4·3H2O, >98%,
Kanto Chemical, Chuo-ku, Tokyo, Japan) as an Au source
and trisodium citrate dihydrate (Na-cit, 99%, Kanto
Chemical) as a reducing reagent. (3-Aminopropyl)
trimethoxysilane (APMS, 97%, Sigma-Aldrich, St. Louis,
MO, USA) were used as a silane coupling agent for in-
creasing the affinity between the Au particle surface and
silica shell. Tetraethyl orthosilicate (TEOS, 95%, Kanto
Chemical), sodium hydroxide (NaOH) aqueous solution
(1 mol/L, Kanto Chemical), and ethanol (99.5%, Kanto
a b c d e
f g h i j
Figure 4 CT images of the internal organs of the mouse after injection. CT images of the liver (red arrows), spleen (blue arrows), and kidney
(pink arrows) of the mouse after injection of Au/SiO2 particle colloid solution. The Au concentration in the colloid solution and the volume of the
injected colloid solution were 0.036 M and 80 μL, respectively. The images were taken (a, f) prior to injection and at (b, g) 5, (c, h) 360, (d, i)
1,440, and (e, j) 2,880 min after injection.
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sol–gel reaction of TEOS, and a solvent for silica coating,
respectively. Hydrofluoric acid (HF, 46.0% to 48.0%, Kanto
Chemical), nitric acid (HNO3, 69% to 70%, Kanto Chem-
ical), and hydrochloric acid (HCl, 35.0% to 37.0%, Kanto
Chemical) were used for preparing samples for ICP spec-
trometry. All chemicals were used as received. Water that
was ion-exchanged and distilled with Yamato WG-250
(Koto-ku, Tokyo, Japan) was used in all the preparation.
Preparation of materials
A colloid solution of Au/SiO2 particles was prepared in
two steps, as reported in our previous work [40]. The
first step was preparation of the Au nanoparticle colloid
















Figure 5 CT values of the internal organs of the mouse after
injection. CT values of the liver (filled circle), spleen (empty circle),
and kidney (triangle) of the mouse as a function of time after
injection of Au/SiO2 particle colloid solution. The Au concentration
in the colloid solution and the volume of the injected colloid
solution were 0.036 M and 80 μL, respectively.Na-cit aqueous solution to an HAuCl4 aqueous solution
at a constant temperature of 80°C under vigorous stir-
ring. Initial concentrations of Au and Na-cit were 2.4 ×
10–4 and 1.6 × 10–3 M, respectively. The total volume of
the final reactant solution was 400 mL. Production of
Au nanoparticles was implied with visual observation for
color change of the solution to wine red after the
addition. According to TEM, the Au nanoparticles had a
volume-average size of 16.9 ± 1.2 nm [40]. The second
step was silica coating of the obtained Au nanoparticles.
The silica coating was performed by a sol–gel method in
the presence of Au nanoparticles. At 15 min after
addition of an APMS aqueous solution to the obtained
Au nanoparticle colloid solution, ethanol and TEOS
were successively added to the colloid solution. The fol-
lowing rapid injection of an NaOH aqueous solution
into the Au/TEOS colloid solution initiated a sol–gel re-
action of TEOS or the silica coating. The reaction
temperature and time were 35°C and 24 h, respectively.
The total volume of the final reactant solution was 2,000
mL. Initial concentrations of Au, APMS, NaOH, H2O,
and TEOS in the final reactant solution were adjusted to
4.3 × 10–5, 2.0 × 10–5, 1.0 × 10–3, 10.7, and 1.0 × 10–2
M, respectively. TEM observation indicated that these
initial concentrations resulted in production of Au/SiO2
particles with a volume-average particle size of 138.9 ±
12.4 nm [40].
Characterization
TEM was used for investigation of the morphology of the
particles. TEM observation was performed with a JEOL
JEM-2000FX II microscope (Akishima-shi, Japan) operat-
ing at 200 kV. To prepare samples for TEM, the particle
colloid solution was dropped on a collodion-coated cop-
per grid, and then its dispersion medium was evaporated
in air followed by in vacuo. Volume-average particle sizes
were determined by measuring dozens of particle
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the concentrated Au/SiO2 particle colloid solution was
determined by ICP. A Shimadzu ICPS-7510 emission
spectrometer (Kyoto, Japan) was used for the ICP. To
prepare samples for the ICP, HF and aqua regia com-
posed of 1:3 (v/v) HNO3/HCl were successively added to
the concentrated Au/SiO2 particle colloid solution to dis-
solve the silica shell and Au nanoparticles, respectively.
Then, the obtained solution was diluted to adjust the Au
concentration to a concentration appropriate to the ICP
measurement. X-ray images and CT values of samples
such as Iopamiron®300, the Au/SiO2 particle colloid solu-
tion, and a mouse injected with the particle colloid solu-
tions were obtained with the Aloka LaTheta LCT-200 CT
system (Mitaka-shi, Japan), according to our previous
work [42]. Prior to the measurement of the CT value for
the Au/SiO2 particle colloid solution, the Au/SiO2 parti-
cles were washed by salting out the Au/SiO2 particles
with addition of a saturated NaCl aqueous solution, re-
moving the supernatant by decantation, and then repeat-
ing a washing process composed of centrifugation,
removal of the supernatant, addition of water, and shak-
ing with a vortex mixer for several times. The Au/SiO2
particle colloid solution was concentrated to 1/2,000 of
its original volume by decreasing the amount of added
water in the washing process (concentrated Au/SiO2 par-
ticle colloid solution). Assuming complete reduction of
HAuCl4 to metallic Au and no loss of particles during
the concentrating process, the concentrated Au/SiO2 par-
ticle colloid solution was considered to have an initial Au
concentration of 0.086 M. The samples were put into a
tube with a diameter of 3.7 cm and a length of 29.5 cm.
The images were taken as if the samples were cut into
round slices. CT values of samples were estimated with
the basis of CT values of −1,000 HU for air and 0 HU for
water. The mouse used was the ICR mouse with the age
of 5 to 6 weeks old. The mouse was put under anesthesia,
and 80 μL of the colloid solution was injected into the
mouse from its tail veins. All sugical processes were
performed for the mouse under anesthesia in accordance
with guidelines approved by the committee on animal ex-
periments of Tohoku University.
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